Close
Close
Treatment Database
Cannabidivarin
Trade Name not avaiable
Orphan Indication Fragile X syndrome
USA Market Approval
USA Designation Date 06-06-2017
Sponsor GW Research Ltd.
Sovereign House, Histon
Cambridge
More about Fragile X syndrome
Free Newsletter
Related Videos
by Scott Harwood
271 views
by Abidemi Uruejoma
406 views
by Abidemi Uruejoma
385 views